Leveraging linked open data by use of innovation leading technologies.

At Phenaris we constantly challenge the status quo in computational drug design and in silico toxicology.

Using cutting edge technologies we provide data, models, and decision support in all aspects of in silico toxicology. We are currently working on multiple solutions to provide data integration, model development, and decision support.

DATA INTEGRATION

In the era of big data, data curation and integration is an absolute requirement for approaching complex research questions. Being part of large scale, industry driven data integration initiatives, we offer our expertise in this area.

MODEL DEVELOPMENT

High quality predictive toxicity models are needed to support risk assessment. Based on high quality data, we provide a set of models for transporter and toxicity endpoints, which are constantly kept up to date.

DECISION SUPPORT

Prioritizing the right compounds is key for successful drug development. Our integrated toxicologcal read across platform supports decision making in all phases of drug discovery. This does not only save time and money, but also animal experiments.

For more information please visit our products and services pages.

Latest News

Phenaris interview in Die Presse

The Austrian newspaper Die Presse has recently published an interview with us as one of the best participants in the i2b businessplan competition 2018: “Start-up-Steckbrief: Nebenwirkungen mittels Software erkennen. Hier[…]

Read more

Phenaris is celebrating 1 year of business

Phenaris just turned one and we are very excited to look back and celebrate what all we have accomplished in this first year of business. Our team has been busy[…]

Read more
ToxPHACTS wins 2nd place at DBT Award 2018

ToxPHACTS wins 2nd place at DBT Award 2018

For the 4th time the Digital Business Trends platform awarded the Digital Business Trends Award 2018 to innovative, future-oriented, digital solutions in the fields of media, information and communication technology. We are very[…]

Read more

Subscribe

Sign up to recieve news and updates from Phenaris.